Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of Hematology & Oncology
|
April 9, 2014
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation
Zoya Gluzman-Poltorak, Sarita R Mendonca, Vladimir Vainstein, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
Shlomzion Aumann, Adir Shaulov, Arnon Haran, et al.
Leukemia & Lymphoma
|
December 29, 2021
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome
Eyal Lebel, Vladimir Vainstein, Maayan Ashkenazi, et al.
Clinical Nuclear Medicine
|
May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk Assessment
Boaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
American Journal of Hematology
|
January 3, 2014
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A Buckley, Megan Othus, Vladimir Vainstein, et al.
Acta Haematologica
|
January 30, 2025
Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia
Uriel Oanunu, Noa Gross Even-Zohar, Shlomzion Aumann, et al.
Cancers
|
November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest
Boaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
Plos One
|
September 15, 2011
Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization
Eva Jager, Vincent H J van der Velden, Jeroen G te Marvelde, et al.
Experimental Hematology & Oncology
|
April 15, 2014
Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects
Mamata S Gokhale, Vladimir Vainstein, Jamie Tom, et al.
European Journal of Haematology
|
December 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission
Avraham Frisch, Chezi Ganzel, Yishai Ofran, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of Hematology & Oncology
|
April 9, 2014
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation
Zoya Gluzman-Poltorak, Sarita R Mendonca, Vladimir Vainstein, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
Shlomzion Aumann, Adir Shaulov, Arnon Haran, et al.
Leukemia & Lymphoma
|
December 29, 2021
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome
Eyal Lebel, Vladimir Vainstein, Maayan Ashkenazi, et al.
Clinical Nuclear Medicine
|
May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk Assessment
Boaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
American Journal of Hematology
|
January 3, 2014
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A Buckley, Megan Othus, Vladimir Vainstein, et al.
Acta Haematologica
|
January 30, 2025
Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia
Uriel Oanunu, Noa Gross Even-Zohar, Shlomzion Aumann, et al.
Cancers
|
November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest
Boaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
Plos One
|
September 15, 2011
Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization
Eva Jager, Vincent H J van der Velden, Jeroen G te Marvelde, et al.
Experimental Hematology & Oncology
|
April 15, 2014
Single low-dose rHuIL-12 safely triggers multilineage hematopoietic and immune-mediated effects
Mamata S Gokhale, Vladimir Vainstein, Jamie Tom, et al.
European Journal of Haematology
|
December 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission
Avraham Frisch, Chezi Ganzel, Yishai Ofran, et al.
Page
of 5